Literature for peptidase S01.231: urokinase-type plasminogen activator
(References are filtered for relevance to Mutation. To remove the filter click here. See explanation.)
-
Paterson,A.D., Rommens,J.M., Bharaj,B., Blavignac,J., Wong,I., Diamandis,M., Waye,J.S., Rivard,G.E. and Hayward,C.P.
Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene
Blood115, 1264-1266. PubMed Europe PubMed DOI M -
Pesaresi,M., Batelli,S., Prato,F., Polito,L., Lovati,C., Scarpini,E., Quadri,P., Mariani,C., Albani,D. and Forloni,G.
The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level
Neurobiol Dis25, 609-613. PubMed Europe PubMed DOI M -
Beqaj,S.H., Post,D. and Ryan,J.M.
Single-nucleotide polymorphism of the urokinase-plasminogen activator gene during aging and transformation of human diploid kidney cell cultures
In Vitro Cell Dev Biol Anim39, 343-347. PubMed Europe PubMed DOI M
2010
2007
2003
